U.S., Dec. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07298772) titled 'A Study of SHR-4375 Injection in Combination With Other Antitumor Therapies in Patients With Solid Tumors' on Dec. 09.

Brief Summary: This is an open label, multi-center, Phase Ib/II study to evaluate the safety, tolerability and efficacy of SHR-4375 injection in combination with other antitumor therapies in patients with advanced solid tumors.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumor

Intervention: DRUG: SHR-4375 Injection

SHR-4375 injection.

DRUG: Bevacizumab Injection

Bevacizumab injection.

DRUG: Fluorouracil injection

Fluorouracil injection.

DRUG: Calcium Folinate Injecti...